Xinyi Glass (XYIGF)
(Delayed Data from OTC)
$1.02 USD
-0.03 (-2.86%)
Updated Jul 17, 2024 11:24 AM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
XYIGF 1.02 -0.03(-2.86%)
Will XYIGF be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for XYIGF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for XYIGF
2 Stocks to Watch in the Prospering Glass Products Industry
Should Value Investors Buy Xinyi Glass (XYIGF) Stock?
XYIGF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Zacks Industry Outlook Highlights Xinyi Glass, Apogee Enterprises and View
3 Glass Products Stocks to Watch Amid Industry Woes
Are Investors Undervaluing Xinyi Glass (XYIGF) Right Now?
Other News for XYIGF
Xinyi Glass Announces Final Dividend and Scrip Option
Xinyi Glass Offers Dividend Scrip Option
Xinyi Glass Unveils Board and Committee Lineup
Xinyi Glass AGM Concludes with Positive Outcomes